alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Northern Regional Office * 4800 Enterprise Way* Modesto, California 95356-9322 * (209) 557-6400 * FAX (209) 557-6475 

Central Regional Office * 1990 East Gettysburg Avenue * Fresno, California 93726-0244 * (559) 230-5900 * FAX (559) 230-6061 

 Southern Regional Office * 34946 Flyover Court * Bakersfield, California 93308 * (661) 392-5500 * FAX (661) 392-5585 

CMP-17 Revised: January 2009 

San Joaquin Valley Air Pollution Control District

www.valleyair.org

 Modification Form - 

For Changes to Conservation Management Practices Plans

1. CMP PLAN ID (e.g. C-1234-CMPP-0): 

2. CMP PLAN TO BE ISSUED TO: 

3. TOTAL FARM ACREAGE and/or TOTAL ANIMAL COUNT AFTER MODIFICATION TO CMP PLAN:

4. DESCRIPTION OF MODIFICATION: 

CROP/AFO/AREA TYPE* DESCRIPTION

GRAPES (example) INCREASED FARMING ACREAGE FROM 200 TO 400 ACRES

UNPAVED ROAD (example) USING DUST SUPPRESSANT INSTEAD OF WATER

 

 

 

 

• Has District staff assisted you with filling out this Modification Form? NO YES 

5. TYPE OR PRINT NAME OF APPLICANT: TITLE OF APPLICANT: 

6. SIGNATURE OF APPLICANT: DATE: 

7. MAILING ADDRESS: PHONE #: ( ) 

FAX #: ( ) 

E-MAIL: 

Getting Help: If you need help or have questions about filling out this application please contact the Small Business Assistant Offices in 

your area. In the Bakersfield area call (661) 326-6969, in the Modesto area call (209) 557-6446, or in the Fresno area call (559) 230-5888.

-INSTRUCTIONS-

 Line 1. Indicate your CMP Plan ID.

 Line 2. Indicate the name of the business as you would like to appear on your CMP Plan.

Line 3. Indicate the total farm acreage and/or total animal count after making changes to your CMP Plan. 

Line 4. Describe the modifications. *AFO type is a dairy, feedlot, or poultry operation. Area type is the unpaved road or unpaved 

vehicle/equipment area. 

 Line 5. Type or print the name of the applicant followed by the title of the applicant. The applicant must be an officer of the business 

who will be responsible for complying with CMP conditions. 

Line 6. Sign and date the application in ink. 

Line 7: Print the mailing address. Also include the daytime telephone number, FAX number, and e-mail address of the applicant, if 

available.

FOR APCD USE ONLY: 

DATE STAMP: 

 PROJECT #: FACILITY ID:
EXHIBIT 32.02

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of DRYCLEAN USA, Inc. (the "Company") on
Form 10-QSB for the quarter ended September 30, 2004, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I,
Venerando J. Indelicato, Principal Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 that, to the best of my knowledge:

       (1)    The Report fully complies with the requirements of Section 13(a)
              or 15(d) of the Securities Exchange Act of 1934; and

       (2)    The information contained in the report fairly presents, in all
              material respects, the financial condition and results of
              operations of the Company.

November 10, 2004

                                            /s/ Venerando J. Indelicato
                                            -----------------------------------
                                            Venerando J. Indelicato
                                            Principal Financial Officer
|                                                                            
|----------------------------------------------------------------------------
|                                                                            
|View History:  Monthly  Annual Download Data (XLS File)                    
|View History:  Monthly  Annual                                              
|View History:  Monthly  Annual                                              
|View History:                                                               
|                                                                            
|Texas Natural Gas Gross Withdrawals from Coalbed Wells  (Million Cubic Feet)
|                                                                            
|                                                                            
|Texas Natural Gas Gross Withdrawals from Coalbed Wells  (Million Cubic Feet)
|                                                                            

|Decade                                                                                                                            | Year-0 | Year-1 | Year-2 | Year-3 | Year-4 | Year-5 | Year-6 | Year-7 | Year-8 | Year-9
|--------------------------------------------------------------------------------------------------------------------------------- | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------
|2000's                                                                                                                            |        |        | 0      | 0      | 0      | 0      | 0      | 0      | 0      | 0     
|2010's                                                                                                                            | 0      | 0      | 0      | 0      | 0      | 0      | 0      | 0      | 7,120  | 6,738 
|2020's                                                                                                                            | 6,790  | 6,629  | 5,436  |        |        |        |        |        |        |       
|- = No Data Reported;  -- = Not Applicable;  NA = Not Available;  W = Withheld to avoid disclosure of individual company data.
|                                                                                                                                 
|Release Date: 5/31/2024                                                                                                          
|Next Release Date: 6/28/2024
#### CAMPAYNO, D. v. AUTO-OWNERS INSURANCE

1210 WDA 2016

Superior Court of Pennsylvania.

08/23/2017

6743 of 2013

(Westmoreland)

Affirmed
From: David Ozonoff [dozonoff@bu.edu] Sent: Wednesday, December 01, 2004 3:51 PM To: Henshaw, Russell Subject: Reconsideration of CLL

Dear Dr. Henshaw This is in response to your query concerning my views on compensating CLL as a radiation related disease now being considered by the Office of Compensation Analysis and Support. This as been an area of interest of mine and I welcome the opportunity to present my views. I have examined the Reconsideration document you provided me (as well as a number of other pertinent documents) and I find its argument for including CLL as compensable well founded and well supported. The arguments for continued exclusion are not only weak, but lacking in foundation. Considering that all blood cells come from a common progenitor stem cell it has always seemed plausible to me that any cancer of the blood system could be radiation related. This is now generally accepted as true for benzene, which also affects progenitor stem cells (see forthcoming article in Science to this effect by Lan et al.) The specific cell type would depend on just where in the differentiation series the alteration to a malignant phenotype occurred. It is well known that malignancies can "change" their cell lineage during the course of the disease. We tend to forget that the four "forms" of leukemia (ALL, AML, CML and CLL) are designations made on clinical grounds and are related to prognosis and management rather than etiology. Indeed if one wanted to employ cell surface markers, there could be hundreds or even thousands of "different" types of leukemia. This would not make them different from the standpoint of etiology however. Thus while the type of leukemia is very important if one wants to treat the disease it is incorrect to assume this is related to etiology. Just as the difference between a fracture of the thigh bone and the wrist bone is extremely important for treatment and management of a fracture, it says nothing about the etiology of either. In summary, my expert opinion supports including CLL as a radiogenic cancer and against the continuing, and it seems to me, arbitrary practice of exclusion. I hope you find this helpful. Sincerely yours

dave ozonoff

-- David Ozonoff, MD, MPHProfessor of Environmental Health Boston University School of Public Health 715 Albany Street Boston, MA 02118 tel. (617) 638-4620/fax. (617) 638-4857 e-mail: dozonoff@bu.edu web site: http://www.bu.edu/dbin/sph/departments/environmental_health/index.php
No. 12-703.

#### Anderson *v.*AstraZeneca, L. P.

C. A. 8th Cir. Certiorari denied.